| Issue | Title | |
| Vol 23, No 4 (2016) | Negative predictive value of preoperative computed tomography in determining pathologic local invasion, nodal disease, and abdominal metastases in gastric cancer | Abstract PDF HTML |
| D.J. Kagedan, F. Frankul, A. El-Sedfy, C. McGregor, M. Elmi, B. Zagorski, M.E. Dixon, A.L. Mahar, J. Vasilevska-Ristovska, L. Helyer, C. Rowsell, C.J. Swallow, C.H. Law, N.G. Coburn | ||
| Vol 21, No 1 (2014) | Neoadjuvant endocrine treatment for breast cancer: from bedside to bench and back again? | Abstract PDF HTML |
| R.R. Saleh, N. Bouganim, J. Hilton, A. Arnaout, M. Clemons | ||
| Vol 19, No 3 (2012) | Neoadjuvant erlotinib and surgical resection of a stage IIIA papillary adenocarcinoma of the lung with an L861Q activating EGFR mutation | Abstract PDF HTML |
| M. Ong, K. Kwan, S. Kamel-Reid, M. David Vincent | ||
| Vol 24, No 5 (2017) | Neoadjuvant systemic therapy in breast cancer: use and trends in radiotherapy practice | Abstract PDF HTML |
| T.A. Koulis, K. Beecham, C. Speers, S. Tyldesley, D. Voduc, C. Simmons, R. Olson | ||
| Vol 25, No 5 (2018) | Neoadjuvant therapy for breast cancer: updates and proceedings from the Seventh Annual Meeting of the Canadian Consortium for Locally Advanced Breast Cancer | Abstract PDF HTML |
| A. Arnaout, J. Lee, K. Gelmon, B. Poirier, F. I. Lu, M. Akra, J. F. Boileau, K. Tonkin, H. Li, C. Illman, C. Simmons, D. Grenier | ||
| Vol 25, No 2 (2018) | Neutrophil–lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer | Abstract PDF HTML |
| S. Chae, K.M. Kang, H.J. Kim, E. Kang, S.Y. Park, J.H. Kim, S.H. Kim, S.W. Kim, E.K. Kim | ||
| Vol 20, No 2 (2013) | New chart review data validates administrative data- based indicator for guideline-recommended treatment of locally advanced non-small cell lung cancer and shed light on reasons for non-referral and non-treatment | Abstract PDF HTML |
| J. Klein–Geltink, T. Forte, R. Rahal, G. Darling, W. Cheung, R. Alvi, G. Noonan, C. Russell, K. Vriends, J. Niu, G. Lockwood, H. Bryant | ||
| Vol 14, No 1 (2007) | New Multidisciplinary Prostate Bone Metastases Clinic---First of its Kind in Canada | Abstract PDF |
| Philiz Goh, Kristin Harris, Julie Napolskikh, Edward Chow, Emily Sinclair, Urban Emmenegger, Sharon Lemon, Albert Yee, Lesia Wynnychuk, Jeff Myers, Cyril Danjoux, Yoo-Joung Ko | ||
| Vol 24, No 6 (2017) | No evidence of excessive cancer screening in female noncarriers from BRCA1/2 mutation–positive families | Abstract PDF HTML |
| S. Guedaoura, S. Pelletier, W.D. Foulkes, P. Hamet, J. Simard, N. Wong, Z. El Haffaf, J. Chiquette, M. Dorval | ||
| Vol 16, No 4 (2009) | Non-adenomatous non-epithelial carcinoma (hemangiopericytoma) of prostate treated with conservative surgery followed by adjuvant chemoradiation | Details PDF |
| Bikramjit Chakrabarti, Sajal Kumar Ghosh, Suman Ghorai, Bishan Basu, Phalguni Gupta, Suparna Ghosh Ray, Chaitparna Das | ||
| Vol 21, No 3 (2014) | Non-myeloablative allogeneic hematopoietic transplantation for patients with hematologic malignancies: 9-year single-centre experience | Abstract PDF HTML |
| N.I. AlJohani, K. Thompson, W. Hasegawa, D. White, A. Kew, S. Couban | ||
| Vol 22, No 4 (2015) | Nonsurgical treatment of recurrent glioblastoma | Abstract PDF HTML |
| O. Gallego | ||
| Vol 22, No 1 (2015) | Novel agents and associated toxicities of inhibitors of the pi3k/Akt/mtor pathway for the treatment of breast cancer | Abstract PDF HTML |
| S. Chia, S. Gandhi, A.A. Joy, S. Edwards, M. Gorr, S. Hopkins, J. Kondejewski, J.P. Ayoub, N. Califaretti, D. Rayson, S. Dent | ||
| Vol 16, No 3 (2009) | Novel developments in angiogenesis cancer therapy | Details PDF |
| Hal W Hirte | ||
| Vol 20, No 4 (2013) | Nutrition and exercise interventions for patients with lung cancer appear beneficial, but more studies are required | Abstract PDF HTML |
| N. Kiss, E. Isenring | ||
| Vol 18, No 3 (2011) | O. Harold Warwick: Canada’s first medical oncologist | Abstract PDF HTML |
| D. H. Cowan | ||
| Vol 19, No 4 (2012) | Occult cause of paraneoplastic acanthosis nigricans in a patient with known breast dcis: case and review | Abstract PDF HTML |
| B. D. Jakubovic, H. F. Sawires, D. N. Adam | ||
| Vol 25, No 3 (2018) | Ode to my Oncologist | Abstract PDF HTML |
| C.A. Heykoop | ||
| Vol 20, No 5 (2013) | Oncofertility in Canada: an overview of Canadian practice and suggested action plan | Abstract PDF HTML |
| R. Ronn, H.E.G. Holzer | ||
| Vol 21, No 1 (2014) | Oncofertility in Canada: cryopreservation and alternative options for future parenthood | Abstract PDF HTML |
| R. Ronn, H.E.G. Holzer | ||
| Vol 20, No 6 (2013) | Oncofertility in Canada: gonadal protection and fertility-sparing strategies | Abstract PDF HTML |
| R. Ronn, H.E.G. Holzer | ||
| Vol 20, No 4 (2013) | Oncofertility in Canada: the impact of cancer on fertility | Abstract PDF HTML |
| R. Ronn, H.E.G. Holzer | ||
| Vol 22, No 6 (2015) | Oncologist heal thyself: hallmarks of happiness | Abstract PDF HTML |
| C. Jacobs, M. Clemons, A.A. Joy | ||
| Vol 26, No 1 (2019) | Oncology Association of Naturopathic Physicians: Principles of Care Guidelines | Abstract PDF HTML |
| E. Marsden, G. Nigh, S. Birdsall, H. Wright, M. Traub | ||
| Vol 25, No 6 (2018) | Oncology communities of practice: insights from a qualitative analysis | Abstract PDF HTML |
| W. Fingrut, L. A. Beck, D. Lo | ||
| Vol 25, No 3 (2018) | Oncology education for Canadian internal medicine residents: the value of participating in a medical oncology elective rotation | Abstract PDF HTML |
| N.A. Nixon, H. Lim, C. Elser, Y.J. Ko, R. Lee-Ying, V.C. Tam | ||
| Vol 25, No 3 (2018) | Oncology education for internal medicine residents: a call for action! | Abstract PDF HTML |
| T. Younis, B. Colwell | ||
| Vol 21, No 1 (2014) | Oncology education in Canadian undergraduate and postgraduate medical programs: a survey of educators and learners | Abstract PDF HTML |
| V.C. Tam, S. Berry, T. Hsu, S. North, A. Neville, K. Chan, S. Verma | ||
| Vol 22, No 3 (2015) | Ondansetron rapidly dissolving film for the prophylactic treatment of radiation-induced nausea and vomiting—a pilot study | Abstract PDF HTML |
| E. Wong, N. Pulenzas, G. Bedard, C. DeAngelis, L. Zhang, M. Tsao, C. Danjoux, N. Thavarajah, B. Lechner, R. McDonald, P.M. Cheon, E. Chow | ||
| Vol 21, No 3 (2014) | One compared with two cycles of mitomycin C in chemoradiotherapy for anal cancer: analysis of outcomes and toxicity | Abstract PDF HTML |
| R. Yeung, Y. McConnell, G. Roxin, R. Banerjee, G.B. Roldán Urgoiti, A.R. MacLean, W.D. Buie, K.E. Mulder, M.M. Vickers, K.J. Joseph, C.M. Doll | ||
| Vol 17, No 2 (2010) | One year of complete clinical response in a metastatic breast cancer patient treated with a combination of lapatinib and gemcitabine | Abstract PDF |
| J. M. Gasent Blesa, J. B. Laforga Canales, V. Alberola Candel | ||
| Vol 25, No 5 (2018) | Only if you view it through a different lens | Abstract PDF HTML |
| A. Abusanad | ||
| Vol 20, No 3 (2013) | Opportunistic salpingectomy: the way forward—response to Steven Narod | Abstract PDF HTML |
| D.M. Miller, J.N. McAlpine, C.B. Gilks, D.G. Huntsman | ||
| Vol 25, No 5 (2018) | Opportunity is the greatest barrier to providing palliative care to advanced colorectal cancer patients: a survey of oncology clinicians | Abstract PDF HTML Supplemental Material |
| M. A. Earp, A. Sinnarajah, M. Kerba, P. A. Tang, J. Rodriquez-Arguello, S. King, S. M. Watanabe, J. E. Simon | ||
| Vol 14, No 5 (2007) | Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer | Details PDF |
| Michael Fung-Kee-Fung, Thomas Oliver, Laurie Elit, Holger W Hirte, Peter Bryson | ||
| Vol 19, No 4 (2012) | Optimal prophylactic and definitive therapy for bicalutamide-induced gynecomastia: results of a meta-analysis | Abstract PDF HTML |
| M. A. Tunio, M. Al-Asiri, A. Al-Amro, Y. Bayoumi, M. Fareed | ||
| Vol 22 (2015): Updated Guidelines, Consensus and Evidence-Based Reports in Breast Cancer | Optimal systemic therapy for early breast cancer in women: a clinical practice guideline | Abstract PDF HTML |
| A. Eisen, G.G. Fletcher, S. Gandhi, M. Mates, O.C. Freedman, S.F. Dent, M.E. Trudeau, members of the Early Breast Cancer Systemic Therapy Consensus Panel | ||
| Vol 16, No 3 (2009) | Optimal use of taxanes in metastatic breast cancer | Abstract PDF |
| Karen M King, Sasha Lupichuk, Lubna Baig, Marc Webster, Sanraj Basi, Darlene Whyte, Serena Rix | ||
| Vol 21, No 5 (2014) | Optimism about breakthroughs in the age of targeted therapy: the Canadian Lung Cancer Conference 2014; Vancouver, British Columbia; February 7, 2014 | Abstract PDF HTML |
| B. Melosky, C. Ho | ||
| Vol 21, No 1 (2014) | Optimizing outcomes with azacitidine: recommendations from Canadian centres of excellence | Abstract PDF HTML |
| R.A. Wells, B. Leber, N.Y. Zhu, J.M. Storring | ||
| Vol 16, No 4 (2009) | Optimizing the management of advanced non-small-cell lung cancer: a personal view | Abstract PDF |
| Mark D. Vincent | ||
| Vol 17, No 4 (2010) | Optimizing the management of HER2-positive early breast cancer: the clinical reality | Abstract PDF |
| Su. Verma, S. Lavasani, J. Mackey, K. Pritchard, M. Clemons, S. Dent, J. Latreille, J. Lemieux, L. Provencher, Sh. Verma, S. Chia, B. Wang, D. Rayson | ||
| Vol 25, No 4 (2018) | Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer—a survey of oncology nurses and physicians | Abstract PDF Supplemental Material HTML |
| N. LeVasseur, C. Stober, K. Daigle, A. Robinson, S. McDiarmid, S. Mazzarello, B. Hutton, A. Joy, D. Fergusson, J. Hilton, M. McInnes, M. Clemons | ||
| Vol 24, No 4 (2017) | Oral Chinese herbal medicine as maintenance treatment after chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis | Abstract PDF HTML |
| Q. Wang, Q. Wang, S.F. Wang, L.J. Jiao, R.X. Zhang, Y. Zhong, J. Zhang, L. Xu | ||
| Vol 24, No 6 (2017) | Orbital mass as first presentation of metastatic p16-positive oropharyngeal squamous cell carcinoma | Abstract PDF HTML |
| J. Corbett, D. Wilke, J. Trites, N. Lamond | ||
| Vol 23 (2016): Original Cancer Costing Research Using Canadian Data | Original Canadian cancer costing research for cancer control sustainability, quality, and value | Abstract PDF HTML |
| H. Bryant | ||
| Vol 21, No 3 (2014) | Ottawa Cardiac Oncology Program wins 2013 Cancer Quality Council of Ontario Innovation Award | Abstract PDF HTML |
| J. Sulpher, C. Johnson, M. Turek, A. Law, E. Stadnick, S. Hopkins, N. Graham, S.F. Dent | ||
| Vol 22 (2015): Updated Guidelines, Consensus and Evidence-Based Reports in Breast Cancer | Outcome of patients with pregnancy during or after breast cancer: a review of the recent literature | Abstract PDF HTML |
| J. Raphael, M.E. Trudeau, K. Chan | ||
| Vol 25, No 6 (2018) | Outcomes by treatment modality in elderly patients with localized gastric and esophageal cancer | Abstract PDF HTML |
| A. Natori, B. A. Chan, H. W. Sim, L. Ma, D. W. Yokom, E. Chen, G. Liu, G. Darling, C. Swallow, S. Brar, J. Brierley, J. Ringash, R. Wong, J. Kim, P. Rogalla, S. Hafezi-Bakhtiari, J. Conner, J. Knox, E. Elimova, R. W. Jang | ||
| Vol 19, No 4 (2012) | Outcomes of accelerated hypofractionated radiotherapy in stage I non-small-cell lung cancer | Abstract PDF HTML |
| T. Yung, M. E. Giuliani, L. W. Le, A. Sun, B.C.J. Cho, A. Bezjak, A. Brade, A. J. Hope | ||
| Vol 20, No 6 (2013) | Outcomes of her2-positive early-stage breast cancer in the trastuzumab era: a population-based study of Canadian patients | Abstract PDF HTML |
| U. Zurawska, D.A. Baribeau, S. Giilck, C. Victor, S. Gandhi, A. Florescu, S. Verma | ||
| Vol 19, No 3 (2012) | Outcomes of surveillance for contralateral breast cancer in patients less than age 60 at the time of initial diagnosis | Abstract PDF HTML |
| C. Weinstock, R. Bigenwald, T. Hochman, P. Sun, S.A. Narod, E. Warner | ||
| Vol 19, No 4 (2012) | Outcomes of women with early-stage breast cancer receiving adjuvant trastuzumab | Abstract PDF HTML |
| M. D. Seal, C. H. Speers, S. O'Reilly, K. A. Gelmon, S. L. Ellard, S. K. Chia | ||
| Vol 24, No 2 (2017) | Ovarian cancer in Manitoba: trends in incidence and survival, 1992–2011 | Abstract PDF HTML |
| P. Lambert, K. Galloway, A. Altman, M.W. Nachtigal, D. Turner | ||
| Vol 24, No 6 (2017) | Ovarian function after chemotherapy in young breast cancer survivors | Abstract PDF HTML |
| K. Morarji, O. McArdle, K. Hui, G. Gingras-Hill, S. Ahmed, E.M. Greenblatt, E. Warner, S. Sridhar, A.M.F. Ali, A. Azad, D.C. Hodgson | ||
| Vol 20, No 2 (2013) | Overall survival should be the primary endpoint in clinical trials for advanced non-small cell lung cancer | Abstract PDF HTML |
| P.K. Cheema, R.L. Burkes | ||
| Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist | Overcoming endocrine resistance in hormone receptor–positive breast cancer | Abstract PDF HTML |
| A. AlFakeeh, C. Brezden-Masley | ||
| Vol 25, No 3 (2018) | Overcoming resistance in a BRAF V600E–mutant adenocarcinoma of the lung | Abstract PDF HTML |
| T. Schmid, M. Buess | ||
| Vol 22, No 1 (2015) | Overdiagnosis in breast cancer chemoprevention trials | Abstract PDF HTML |
| V. Sopik, S.A. Narod | ||
| Vol 25, No 2 (2018) | Overwhelming research and clinical evidence of exercise medicine efficacy in cancer management—translation into practice is the challenge before us | Abstract PDF HTML |
| R.U. Newton | ||
| Vol 18, No 1 (2011) | Oxaliplatin: a review in the era of molecularly targeted therapy | Abstract PDF HTML |
| T. Alcindor, N. Beauger | ||
| Vol 19 (2012): Oncology in China | Oxidative DNA damage of lymphocytes in peripheral blood and ascites in cancer patients | Abstract PDF HTML |
| J. Wang, S. S. Xing, S. B. Guo, W. Jin, W. Zhang | ||
| Vol 20, No 4 (2013) | Pain assessment during conscious sedation for cervical cancer high-dose-rate brachytherapy | Abstract PDF HTML |
| H. Bhanabhai, R. Samant, C. E, L. Grenier, S. Lowry | ||
| Vol 23, No 5 (2016) | Painless neutropenic enterocolitis in a patient undergoing chemotherapy | Abstract PDF HTML |
| E.J. Chow, K.D. Bishop | ||
| Vol 24, No 3 (2017) | Palliative care as a public health issue: understanding disparities in access to palliative care for the homeless population living in Toronto, based on a policy analysis | Abstract PDF HTML |
| B. Henry, N. Dosani, L. Huynh, N. Amirault | ||
| Vol 26, No 1 (2019) | Palliative care consultation and aggressive care at end of life in unresectable pancreatic cancer | Abstract PDF HTML |
| C. Lees, S. Weerasinghe, N. Lamond, T. Younis, Ravi Ramjeesingh | ||
| Vol 26, No 1 (2019) | Palliative care for cancer patients near end of life in acute-care hospitals across Canada: a look at the inpatient palliative care code | Abstract PDF HTML |
| J. Tung, J. Chadder, D. Dudgeon, C. Louzado, J. Niu, R. Rahal, A. Sinnarajah | ||
| Vol 22, No 5 (2015) | Palliative chemotherapy for patients 70 years of age and older with metastatic colorectal cancer: a single-centre experience | Abstract PDF HTML |
| D. Bossé, M. Vickers, F. Lemay, A. Beaudoin | ||
| Vol 23, No 3 (2016) | Palliative chemotherapy in advanced colorectal cancer patients 80 years of age and older | Abstract PDF HTML |
| P. Lai, S. Sud, T. Zhang, T. Asmis, P. Wheatley-Price | ||
| Vol 21, No 2 (2014) | Palliative sedation— still a complex clinical issue! | Abstract PDF HTML |
| R.L. Fainsinger | ||
| Vol 18, No 3 (2011) | Pan-Canadian initiatives in colorectal cancer screening: adopting knowledge translation tools to accelerate uptake and impact | Abstract PDF HTML |
| H. E. Bryant, S. V. Fekete, D. H. Major | ||
| 2008: Presentations from the Integrating Wellness into Cancer Care Conference | Panel Discussion 1 | Abstract PPT Presentation |
| S Sutcliffe, G. Deng, L. Wright, J. Maher, S. Sagar | ||
| 2008: Presentations from the Integrating Wellness into Cancer Care Conference | Panel Discussion 2 | Abstract PPT Presentation |
| M. Philp, G. Payne, A. Cunningham, M. Vachon | ||
| 2008: Presentations from the Integrating Wellness into Cancer Care Conference | Panel Discussion 3 | Abstract PPT Presentation |
| B. Bell, Terry Sullivan, M. Vachon, P. Catton, A. Jadad, L. Morrison | ||
| Vol 20, No 6 (2013) | Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancer | Abstract PDF HTML |
| H. Kennecke, L. Chen, C.D. Blanke, W.Y. Cheung, K. Schaff, C. Speers | ||
| Vol 24, No 5 (2017) | Papillary thyroid carcinoma in a boy with familial tuberous sclerosis complex attributable to a TSC2 deletion—a case report | Abstract PDF HTML |
| M. Flader, P. Kurzawa, J. Maldyk, J. Sygut, J. Harasymczuk, A. Kropinska, D. Handkiewicz-Junak, B. Jarzab, K. Kotulska, M. Niedziela | ||
| Vol 22, No 6 (2015) | Para-aortic and pelvic extended-field radiotherapy for advanced-stage uterine cancer: dosimetric and toxicity comparison between the four-field box and intensity-modulated techniques | Abstract PDF HTML |
| A. Rabinovich, L. Bernard, A.V. Ramanakumar, G. Stroian, W.H. Gotlieb, S. Lau, B. Bahoric | ||
| Vol 25, No 5 (2018) | Paroxysmal nocturnal hemoglobinuria testing in patients with myelodysplastic syndrome in clinical practice—frequency and indications | Abstract PDF HTML |
| S. A. Wong, B. I. Dalal, H. A. Leitch | ||
| Vol 16, No 6 (2009) | Partial cancerous changes eventually developing into superficial spreading cancer over 18 months | Abstract PDF |
| Y. Song, Z. Wang, Q. Tang, H. Xu, C. Xing, Z. Miao, C. Yang | ||
| Vol 17, No 1 (2010) | Pathology re-review as an essential component of breast cancer management | Abstract PDF |
| C.G. Kleer | ||
| Vol 18 (2011): The Optimization of Hormonal Therapy in Early Breast Cancer | Patient adherence to aromatase inhibitor treatment in the adjuvant setting | Abstract PDF HTML |
| S. Verma, Y. Madarnas, S. Sehdev, G. Martin, J. Bajcar | ||
| Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective | Patient Decision-Making about Complementary and Alternative Medicine (CAM) in Cancer Management: The Context and Process | Abstract PDF |
| Lynda G Balneaves | ||
| Vol 26, No 1 (2019) | Patient indications for Mohs micrographic surgery: a clinical practice guideline | Abstract PDF HTML |
| C. Murray, D. Sivajohanathan, T. P. Hanna, S. Bradshaw, N. Solish, B. Moran, R. Hekkenberg, A. C. Wei, T. Petrella | ||
| Vol 21, No 2 (2014) | Patient perceptions of a comprehensive cancer navigation service | Abstract PDF HTML |
| W. Hryniuk, R. Simpson, A. McGowan, P. Carter | ||
| Vol 19 (2012): Improving Patient Outcomes in Advanced Prostate Cancer | Patient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regret | Abstract PDF HTML |
| J. Aning, R.J. Wassersug, S.L. Goldenberg | ||
| Vol 21, No 2 (2014) | Patient preferences for stopping tyrosine kinase inhibitors in chronic myeloid leukemia | Abstract PDF HTML |
| D. Sanford, R. Kyle, A. Lazo–Langner, I. Chin–Yee, K. Howson–Jan, C. Hsia | ||
| Vol 22, No 4 (2015) | Patient preferences for timing and access to radiation therapy | Abstract PDF HTML |
| I.A. Olivotto, J. Soo, R.A. Olson, L. Rowe, J. French, B. Jensen, A. Pastuch, R. Halperin, P.T. Truong | ||
| Vol 22, No 3 (2015) | Patient with inoperable pheochromocytoma | Abstract PDF HTML |
| D. Brancíková, Z. Mechl, Z. Adam, E. Jandáková, Z. Pavlovský, V. Válek, Z. Andrašina | ||
| Vol 22, No 2 (2015) | Patient-expressed perceptions of wait-time causes and wait-related satisfaction | Abstract PDF HTML |
| M. Mathews, D. Ryan, D. Bulman | ||
| Vol 25, No 6 (2018) | Patient-reported outcome measurement compared with professional judgment of cosmetic results after breast-conserving therapy | Abstract PDF HTML |
| A.T.P.M. Brands-Appeldoorn, A.J.G. Maaskant-Braat, W.A.R Zwaans, J.P. Dieleman, K.E. Schenk, C.L. Broekhuysen, H. Weerdenburg, R. Daniels, V.C.G. Tjan-Heijnen, R.M.H. Roumen | ||
| Vol 25, No 6 (2018) | Patients with advanced cancer: when, why, and how to refer to palliative care services | Abstract PDF HTML |
| C. Courteau, G. Chaput, L. Musgrave, A. Khadoury | ||
| Vol 25, No 5 (2018) | Patients with non-small-cell lung cancer harbouring a BRAF mutation: a multicentre study exploring clinical characteristics, management, and outcomes in a real-life setting: EXPLORE GFPC 02-14 | Abstract PDF HTML |
| J. B. Auliac, S. Bayle, A. Vergnenegre, H. Le Caer, L. Falchero, R. Gervais, H. Doubre, F. Vinas, B. Marin, C. Chouaid | ||
| Vol 21, No 2 (2014) | Patients’ perceptions of gene expression profiling in breast cancer treatment decisions | Abstract PDF HTML |
| Y. Bombard, L. Rozmovits, M.E. Trudeau, N.B. Leighl, K. Deal, D.A. Marshall | ||
| Vol 24, No 6 (2017) | Patterns of cancer centre follow-up care for survivors of breast, colorectal, gynecologic, and prostate cancer | Abstract PDF HTML |
| R. Urquhart, L. Lethbridge, G.A. Porter | ||
| Vol 23, No 1 (2016) | Patterns of care and treatment trends for Canadian men with localized low-risk prostate cancer: an analysis of provincial cancer registry data | Abstract PDF HTML |
| K. Tran, R. Rahal, S. Fung, C. Louzado, G. Porter, J. Xu, H. Bryant | ||
| Vol 24, No 3 (2017) | Patterns of failure in anaplastic and differentiated thyroid carcinoma treated with intensity-modulated radiotherapy | Abstract PDF HTML |
| H. Vulpe, J.Y.Y. Kwan, A. McNiven, J.D. Brierley, R. Tsang, B. Chan, D.P. Goldstein, L.W. Le, A. Hope, M. Giuliani | ||
| Vol 20, No 5 (2013) | Patterns of practice in the prescription of palliative radiotherapy for the treatment of bone metastases at the Rapid Response Radiotherapy Program between 2005 and 2012 | Abstract PDF HTML |
| N. Thavarajah, L. Zhang, K. Wong, G. Bedard, E. Wong, M. Tsao, C. Danjoux, E. Barnes, A. Sahgal, K. Dennis, L. Holden, N. Lauzon, E. Chow | ||
| Vol 23, No 5 (2016) | Patterns of practice with third-line anti-EGFR antibody for metastatic colorectal cancer | Abstract PDF HTML |
| M.Y. Ho, D.J. Renouf, W.Y. Cheung, H.J. Lim, C.H. Speers, C. Zhou, H.F. Kennecke | ||
| Vol 18, No 6 (2011) | Patterns of presentation, referral, and treatment of hepatocellular carcinoma in a pre-sorafenib era: experience of a Canadian provincial cancer agency | Abstract PDF HTML |
| T. Sundaralingam, S. Gill | ||
| Vol 24, No 4 (2017) | Patterns of spread and prognostic implications of lung cancer metastasis in an era of driver mutations | Abstract PDF HTML |
| F. Hsu, A. De Caluwe, D. Anderson, A. Nichol, T. Toriumi, C. Ho | ||
| 901 - 1000 of 1559 Items | << < 5 6 7 8 9 10 11 12 13 14 > >> | |
User
Current Oncology is published by:
Endorsed publication of the Canadian Association of Psychosocial Oncology (CAPO)
